Biotech—it's complicated. A successful product launch requires grit, determination, and clear direction. But let’s be real, the path to launch isn’t a straight one. There are curves, hard turns, and dead ends. Here’s the good news, you don’t have to navigate the complexities alone. Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.
…
continue reading
Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.
…
continue reading
Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering. Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050. Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.
…
continue reading
This podcast aims to bring you a daily summary of the most relevant news in Pharma and BioTech. Check our website at: https://www.buzzsprout.com/2189790
…
continue reading
Welcome to The Biotech Startups Podcast by Excedr. Join us as we speak with first-time founders, experienced scientists, long-time company operators, serial entrepreneurs, and biotech investors about the challenges and triumphs of running a biotech startup. Gain actionable insight into navigating the ever-changing life sciences industry in each episode as we explore the business of science, from pre-seed to IPO. With your host, Jon Chee.
…
continue reading
Data in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences. Every two weeks, Ross Katz, Principal and Data Science Lead at CorrDyn, sits down with an expert from the world of biotechnology to understand how they use data science to solve technical challenges, streamline operations, and further innovation in their business. You can learn more about CorrDyn - an enterprise data specialist that enables excellent companies to make smarter ...
…
continue reading
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is p ...
…
continue reading
Inside Biotech is an exciting podcast from BCLA, which focuses on the science behind SoCal’s most innovative new biotech companies. This semi-monthly podcast, hosted by Gabriella Rubert, Ph.D. Candidate at UCLA and Podcast Lead at BCLA, is the perfect way for anyone interested in LA’s biotech community to stay informed about current progress and developments. Episodes feature conversations with scientists, entrepreneurs, investors, and more about the cutting-edge science that goes on inside ...
…
continue reading
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday.The host is Jim Cornall.
…
continue reading
Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for ...
…
continue reading
Grow Everything reveals the world of biology as technology. Hosts Erum Khan and Karl Schmieder interview leaders and influencers biologizing industries with tools like synthetic biology, precision fermentation, bioprospecting, and more. These companies make biomaterials from waste, cosmetics that restore healthy hair and skin, and delicious cultivated foods in a bioreactor and so much more. Join us as we discuss the latest and greatest across biotech, synbio, entrepreneurship, and culture an ...
…
continue reading
1
Israeli Technology Founders Speak: Conversations with Successful Israeli Hitech and Biotech Entrepreneurs
JMB Davis Ben-David International IP Law Firm
Podcast by JMB Davis Ben-David International IP Law Firm
…
continue reading
In the Biotech Career Coach podcast, we share valuable insights and advice for job seekers and career-minded individuals in the biotechnology and life sciences industry. From resume tips to leadership strategies, this podcast will help you navigate your job search and succeed in your career. This podcast is a production of The Collaboratory Career Hub To join our Community or access great resources, visit www.library.collaboratorycareerhub.com
…
continue reading
From the ground floor to the C-Suite, Building Biotechs offers a behind-the-scenes look into the strategy that goes into launching and scaling successful biotech and life science companies. We talk with biotech executives, founders, HR leaders, and culture builders to learn how they think about growing companies with intention, and discuss the valuable lessons they’ve learned along the way.
…
continue reading
Welcome to the Biotech Bytes podcast, where we sit down with Biotech and Pharma IT leaders to learn what's working in our industry. Steven Swan is the CEO of The Swan Group LLC. He has 20 years of experience working with companies and individuals to make long-term matches. Focusing on Information technology within the Biotech and Pharmaceutical industries has allowed The Swan Group to become a valued partner to many companies. Staying in constant contact with the marketplace and its trends a ...
…
continue reading
In this podcast, entrepreneur and angel investor Flavio Rump discusses the biggest bottlenecks and the future of biotech by speaking with some of the sharpest, most innovative minds in biotechnology and related fields.
…
continue reading
A podcast to share the tools, tips, tricks and routines of the best biotech executives in the industry in order to help develop the next generation of biotech leaders and expedite the launch of new therapies and transform the lives of patients' all over the world.
…
continue reading
Forschungsthemen aus dem Bereich Biotechnologie und Verfahrenstechnik an der TUHH
…
continue reading
Biotech knowledge center
…
continue reading
Matt breaks down relevant biotech stocks, analyzing their data and determining if they are a good investment.
…
continue reading
BioTech Nation Radio with Dr Moira Gunn
…
continue reading
SoyBiotec, es decir, Biotecnólogo. Estudio Biotecnología en mis ratos libres y cuando no, os la cuento por aquí. SoyBiotec y Podcast Biotec son ideas originales de Dani García
…
continue reading
Interviews with innovators at the intersections of science, data, and technology.
…
continue reading
Welcome to the biotech podcast where we talk to the leading scientists in the world about their work, their lives and fundamental questions concerning their field.
…
continue reading
Um grupo de universitários que decidiu se juntar pra falar de Biotecnologia e Ciência e compartilhar isso com o mundo.
…
continue reading
1
Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up for Busy Scientists
David Brühlmann: Biotech Entrepreneur & Cell Culture Technology Innovation Aficionado
The Go-to Podcast for Biotech Scientists Who Want to Master Bioprocess CMC Development and Manufacturing of Biologics. **TOP 10 LIFE SCIENCES PODCAST** Do you want to simplify bioprocessing so that you can scale with confidence and reduce time to market? Are you sick of feeling overwhelmed by the complexity and guesswork of biologics drug development? Do you wish you had more time to enjoy the beauty of science, without worrying about failing your cell culture process development and commerc ...
…
continue reading
Defination Uses Various processes in Tissue - culture
…
continue reading
Between the Biotech Waves—discussing recent developments and market dynamics impacting the biotech sector.
…
continue reading
Illuminating life science career opportunities outside of academia through the experiences of those who have been there before.
…
continue reading
A weekly audio digest of the most important news in drug development affecting the pharmaceutical and biotech industry
…
continue reading
Back of the Napkin is a podcast series from Bio-Techne that meets scientific pioneers. It goes beyond the publications to hear the untold stories from innovation corner, where ideas and discoveries are conceived.
…
continue reading
Horizon 3 is a biotech fund which has been formed to help investors to have a real impact on a range of global health challenges through new bio technologies, aiming to de-risk the investment risks inherent in such a technical area.These podcasts are a series aimed at educating investors on the issues, risks and opportunities involved in investing ion the biotech sector.
…
continue reading
Este podcast explicará qué es la biotecnología y la manipulación genética
…
continue reading
In einer Podcast Folge wird jeweils ein Punkt einer Lernplaneinheit vorgestellt. Viele sind One-Taker meiner eigenen Biotech-Abi Vorbereitung :D Cover art photo provided by Annie Spratt on Unsplash: https://unsplash.com/@anniespratt
…
continue reading
Biotechnology for Tomorrow
…
continue reading
The Biotech Futurist aims to foster deep understanding and discussion about exciting hot topics in biotech at the intersection with artificial intelligence and medicine, exploring CRISPR therapeutics, neuroscience, genetic diseases, interventional genomics, machine learning in biology, behavior, neuroscience, omics, cellular recording, liquid biopsy, oncology, longevity, and more. Your host Luca Fusar Bassini, PhD student at EPFL in Switzerland, interviews an expert guest every week.
…
continue reading
A weekly live audience show featuring the people building and funding companies that are extending healthy human lifespan. Join us Thursdays on Clubhouse and check the show schedule on longevitybiotechshow.com Hosted by Nathan Cheng (founder @ Longevity Marketcap // Longevity List) and Robert Ziman (Cohen Lab).
…
continue reading
From sales to medical affairs, we will help you break into and navigate your career in the biopharma industry!
…
continue reading
Explore the world of cloning, protein folding, genome mapping, and more with the most important researchers in the field. Although the show is no longer in production at TWiT, you can enjoy episodes from the TWiT Archives.
…
continue reading
Explore the world of cloning, protein folding, genome mapping, and more with the most important researchers in the field. Although the show is no longer in production at TWiT, you can enjoy episodes from the TWiT Archives.
…
continue reading
Encode Ideas authors research on publicly traded micro / small cap healthcare (biotech & medtech) companies. The Plainspoken podcast is an extension of our research, where we will interview executives from micro / small cap health care companies, portfolio managers who invest in micro / small cap healthcare, and key opinion leaders who can offer insights into therapeutics areas of interest to investors. The podcast is for entertainment purposes only and should not be considered financial adv ...
…
continue reading
What happens when robots, AI, and big data enter the hospital? Glenn Cohen (a professor and deputy dean at Harvard Law School) is unpacking that question in this exploration of biotechnology, ethics, medical law, and health care policy. Each week, he’ll interrogate a single technology – such as digital pills, AI-powered decision support algorithms, or digital health apps – through the lens of ethical concerns like informed consent, liability, and privacy.
…
continue reading
Interviews with the researchers, founders, and investors of the BioTech industry. An insiders look into what is going on in the world of BioTech, from curing aging to psychedelic therapy, we interview the game changers of the industry. The unsung hero's that are moving the industry forward in a significant way. The world is going to be a vastly different place in the next 10-20 years because of what's happening in the BioTech industry right now.Human civilization will move forward farther, f ...
…
continue reading
1
Pharma and Biotech Daily: Analyzing the Impact of Trump's Win on the Industry
0:55
0:55
Mais Tarde
Mais Tarde
Listas
Like
Curtido
0:55
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Analysts are expressing mixed reactions to Donald Trump's election victory. There are potential positives for the biopharma industry, such as a more friendly FTC for M&A deals. However, concerns have been raised about what…
…
continue reading
1
CRISPR Dilemma... Dr. Eben Kirksey, Anthropologist & Author, “The Mutant Project: Inside the Global Race to Genetically Modify Humans”
38:02
38:02
Mais Tarde
Mais Tarde
Listas
Like
Curtido
38:02
This week on BioTech Nation, we talk with Dr. Eben Kirksey about the ethical issues behind CRISPR, the gene-editing tool that made headlines with the birth of the first “CRISPR babies” in China. Dr. Kirksey shares his experiences investigating this controversial experiment and highlights the deeper questions it raises. He stresses the importance of…
…
continue reading
1
Rob Williamson, CEO of Triumvira, on Biotech’s High-Stakes Path and Cell Therapy Innovations
23:45
23:45
Mais Tarde
Mais Tarde
Listas
Like
Curtido
23:45
Synopsis: Rob Williamson, CEO of Triumvira, joins Biotech 2050 host, Rahul Chaturvedi, to discuss his dynamic career from economics to biotech, tackling the volatile capital markets, and navigating high-stakes decisions in cell therapy. He shares insights on therapeutic developments in cell therapy, the pressures of solid tumor research, and the ev…
…
continue reading
1
Pharma and Biotech Daily: From Gene Editing to Workforce Cuts
0:58
0:58
Mais Tarde
Mais Tarde
Listas
Like
Curtido
0:58
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Beam Therapeutics reported a patient death in a gene editing trial for sickle cell disease, overshadowing otherwise positive data. Beam-101 was found to be competitive with approved treatments, highlighting the need for les…
…
continue reading
1
Pharma and Biotech Daily: Promising Weight Loss Drug, Vaccine Success, and CAR T Therapy for Autoimmune Diseases
0:55
0:55
Mais Tarde
Mais Tarde
Listas
Like
Curtido
0:55
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Viking Therapeutics has reported promising phase I data for their oral weight loss drug, VK2735, with patients on 100-miligram doses losing 8.2% of their body weight after 28 days. Jefferies analyst Roger Song described th…
…
continue reading
1
103: One-Stop Shop vs. Specialist CDMO: A Scientist's Guide to CDMO Selection with Sigma Mostafa - Part 1
24:01
24:01
Mais Tarde
Mais Tarde
Listas
Like
Curtido
24:01
Send us a text In this insightful episode, we're joined by Sigma Mostafa, Chief Scientific Officer at KBI Biopharma, who shares crucial insights on selecting the right CDMO partner for biotech development. Sigma brings a unique blend of scientific rigor and practical experience to the discussion, having worked on both sides of the CDMO relationship…
…
continue reading
1
The New Board Game: Strategic Moves in Biotech
16:43
16:43
Mais Tarde
Mais Tarde
Listas
Like
Curtido
16:43
The relationship between biotech leadership and their boards is evolving, particularly as private equity takes a larger role in the industry. In this episode of the Emerging Biotech Leader, Nick Amigone from Amulet Capital Partners offers a unique perspective on building effective board relationships from the private equity vantage point. The conve…
…
continue reading
1
An Unanticipated Biotech Startup With OS Therapies' Paul Romness
49:12
49:12
Mais Tarde
Mais Tarde
Listas
Like
Curtido
49:12
We love to hear from our listeners. Send us a message. Becoming a biotech CEO wasn't on Paul Romness' bingo card. He'd forged his place in the biopharma industry as a foremost public and policy affairs expert. Thirteen years at J&J, more than 5 at Amgen, and half a dozen at Boehringer Ingelheim had earned him the right to coast into a consulting gi…
…
continue reading
1
🧬Michael Chen - Nuclera - Part 1 | Influence of a Data-Driven Family | Do the Dishes in a Lab | NIH-Oxford Cambridge Scholarship Program | What Got Us Here Won’t Get Us There
52:51
52:51
Mais Tarde
Mais Tarde
Listas
Like
Curtido
52:51
The Biotech Startups Podcast is brought to you by Excedr. Excedr provides life science startups with equipment leases on founder-friendly terms to accelerate R&D and commercialization. Know anyone that needs lab equipment? Join Excedr’s referral program: Give Your Friends $1,000, and Earn $1,000 for Each Qualified Referral 💸. Get your unique referr…
…
continue reading
1
Pharma and Biotech Daily: Top News and Job Opportunities in the Industry
0:47
0:47
Mais Tarde
Mais Tarde
Listas
Like
Curtido
0:47
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Novo Nordisk's weight loss drug Wegovy showed significant improvement in liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis in a Phase III trial. Bristol Myers Squibb reported strong third-qu…
…
continue reading
1
101. Biotech's Glow Up: How Estée Lauder is Leveling Up Skincare with Rocky Graziose
1:00:16
1:00:16
Mais Tarde
Mais Tarde
Listas
Like
Curtido
1:00:16
Rocky Graziose from Estée Lauder is here to discuss the innovative intersection of biotechnology and beauty. With a background in plant natural products chemistry, Rocky brings an insider perspective on how Estée Lauder is pushing boundaries in skincare and cosmetics. He talks about the evolution of the beauty industry and how Estée Lauder’s commit…
…
continue reading
Sitryx Therapeutics is a private UK biopharma company founded in 2018. It is a leader in the field of immunometabolism, an area of immunology that looks to rebalance the immune system to achieve sustained disease remission in autoimmune and inflammatory diseases. Sitryx already has big pharma validation following a deal with Eli Lilly in 2020 worth…
…
continue reading
1
Pharma and Biotech Daily: Merck, Novo, Amgen, AbbVie, FDA Updates, and More!
0:56
0:56
Mais Tarde
Mais Tarde
Listas
Like
Curtido
0:56
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Merck exceeded Q3 expectations but adjusted its 2024 guidance downwards due to underwhelming revenues from Gardasil and Januvia. Novo is making progress in resolving shortages of Ozempic and Wegovy. Amgen is gearing up for…
…
continue reading
1
🧬 Neela Patel - Bonum Therapeutics - Part 4 | Transitioning to Seattle Genetics & Business Development | Insights from Roche’s Acquisition | Building a Transformative Oncology Pipeline with Bonum Therapeutics ...
32:50
32:50
Mais Tarde
Mais Tarde
Listas
Like
Curtido
32:50
Part 4 of 4: Jon Chee hosts our latest guest, Neela Patel, Chief Business Officer at Bonum Therapeutics who are developing protein therapeutics to be used to treat a wide range of diseases. Neela is a seasoned scientist and business development executive with over 30 years of leadership experience in drug discovery and development. Before her time …
…
continue reading
1
Pharma and Biotech Daily: Eli Lilly Stock Drops, Biogen Exceeds Expectations, and More Updates
0:45
0:45
Mais Tarde
Mais Tarde
Listas
Like
Curtido
0:45
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Eli Lilly experienced lower-than-expected sales for its weight loss and diabetes drugs in the third quarter, causing its stock to drop by over 13%. Biogen, on the other hand, exceeded expectations for its Alzheimer's drug …
…
continue reading
1
How Tech Is Solving The Organ Shortage Problem with Shola Oyewole
35:39
35:39
Mais Tarde
Mais Tarde
Listas
Like
Curtido
35:39
The organ shortage crisis is one of modern medicine's greatest challenges, but innovative technologies like 3D printing and AI are changing the game. Please visit our website to get more information: https://swangroup.net/ In this episode, I talk with Shola Oyewole, VP of Digital Innovation at United Therapeutics, to explore how they lead the charg…
…
continue reading
1
102: PAT Revolution: Decoding Your Bioprocess Like Never Before with Katharina Dahlmann - Part 2
15:17
15:17
Mais Tarde
Mais Tarde
Listas
Like
Curtido
15:17
Send us a text Struggling to unravel the complexities of your bioprocess? Prepare for a paradigm shift as we dive into the world of Process Analytical Technology (PAT) with Katharina Dahlmann who is Application and PAT Expert at Hamilton. This eye-opening episode dissects how PAT is redefining biologics manufacturing, balancing its immense potentia…
…
continue reading
1
From Moderna to Dash Bio - Revolutionizing Drug Development with Dave Johnson
32:54
32:54
Mais Tarde
Mais Tarde
Listas
Like
Curtido
32:54
In this episode of Data in Biotech, Ross Katz sits down with Dave Johnson, CEO and co-founder of Dash Bio, a next-gen drug development services company with a mission to revolutionize clinical bioanalysis and streamline drug development. Dave begins the episode by taking us back to the early research days in Moderna, where he helped lay the groundw…
…
continue reading
1
AI & Better Health...Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
12:02
12:02
Mais Tarde
Mais Tarde
Listas
Like
Curtido
12:02
This week on BioTech Nation, Dr. Daniel Kraft talks about how AI can personalize health advice using data from devices like your smartwatch. He explains how this technology can help people make better choices to stay healthy and avoid major illnesses. Dr. Kraft envisions AI as a personal health coach, offering real-time tips and reminders tailored …
…
continue reading
1
Gene Mack, Interim CEO & CFO of Gain Therapeutics: Leading the Charge in Parkinson's Breakthroughs
32:01
32:01
Mais Tarde
Mais Tarde
Listas
Like
Curtido
32:01
Biotech2050 Host, Rahul Chaturvedi, engages with Gene Mack, Interim CEO and CFO of Gain Therapeutics, as he shares his journey from aspiring neurosurgeon to biotech leader. Gene reflects on his career shift from clinical research to Wall Street and eventually operational roles in biotech. He details the development of Gain's lead asset, GT02287, wh…
…
continue reading
1
Pfizer's Q3 Success and Biopharma Updates: A Daily Dose of Pharma and Biotech News
0:54
0:54
Mais Tarde
Mais Tarde
Listas
Like
Curtido
0:54
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Pfizer exceeded Wall Street's expectations in the third quarter, reporting higher revenue and adjusted profit amid pressure from activist investor Starboard Value. CEO Albert Bourla received a much-needed victory as the …
…
continue reading
1
The Science of Success: Transforming Scientific Concepts into Marketable Products with Stacy Frye, co-founder and CCO of Stimulus Bio
39:36
39:36
Mais Tarde
Mais Tarde
Listas
Like
Curtido
39:36
In this episode, I had an engaging conversation with Stacie Frye, co-founder and Chief Commercial Officer of StimulusBio, a life sciences commercialization and venture studio for biotech startups. We discussed how StimulusBio aids startups in operational and commercialization aspects, leveraging Stacie's unique journey across marketing, chemical en…
…
continue reading
Ben Wiener is the founder and managing partner of JumpSpeed, the first and only venture capital fund dedicated to investing in early-stage startups in Jerusalem.Avraham sat down with Ben in the offices of JMB Davis Ben-David in Jerusalem to discuss why Ben started Jumpspeed, what he learned from investing in day one startups, his successes and fail…
…
continue reading
1
The Pharma and Biotech Daily Podcast: Breaking Down the Latest Industry Acquisitions and Promising Therapies
1:08
1:08
Mais Tarde
Mais Tarde
Listas
Like
Curtido
1:08
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.AbbVie has acquired Aliada Therapeutics for $1.4 billion, gaining access to a phase I anti-amyloid antibody and a novel platform for efficient blood-brain barrier transport. Meanwhile, the FDA's accelerated approval progr…
…
continue reading
1
101: PAT Revolution: Decoding Your Bioprocess Like Never Before with Katharina Dahlmann - Part 1
23:12
23:12
Mais Tarde
Mais Tarde
Listas
Like
Curtido
23:12
Send us a text Unlock the hidden potential of your bioprocess! In this eye-opening episode, David Brühlmann sits down with Katharina Dahlmann, Application and PAT Expert at Hamilton, to explore the game-changing world of Process Analytical Technology (PAT). Discover how PAT is revolutionizing biotech by providing unprecedented insights into cell be…
…
continue reading
1
Building On Pandemic Progress With Barinthus Biotherapeutics' Bill Enright
44:14
44:14
Mais Tarde
Mais Tarde
Listas
Like
Curtido
44:14
We love to hear from our listeners. Send us a message. It might just be coincidence, but it sure seems like Bill Enright has a knack for making big moves at inopportune times, then turning the expected outcome on its ear. For example, he signed on as CEO at Altimmune when the company was struggling mightily. Enright had a turnaround plan in hand, b…
…
continue reading
1
🧬 Neela Patel - Bonum Therapeutics - Part 3 | Developing Pipeline Strategy at Poniard Pharmaceuticals | Business & Corporate Development in Oncology | Transitioning from Abbott to AbbVie to Seagen
40:06
40:06
Mais Tarde
Mais Tarde
Listas
Like
Curtido
40:06
Part 3 of 4: Jon Chee hosts our latest guest, Neela Patel, Chief Business Officer at Bonum Therapeutics who are developing protein therapeutics to be used to treat a wide range of diseases. Neela is a seasoned scientist and business development executive with over 30 years of leadership experience in drug discovery and development. Before her time …
…
continue reading
1
Pharma and Biotech Daily: Sanofi's Success, CRISPR Breakthroughs, and Industry Updates
1:16
1:16
Mais Tarde
Mais Tarde
Listas
Like
Curtido
1:16
Good morning from Pharma and Biotech Daily, the podcast that gives you only what's important to hear in Pharma and Biotech world.Sanofi beat third-quarter forecasts with a 381% growth in sales of its newly launched respiratory syncytial virus antibody, Beyfortus, bringing in almost $700 million. Analysts expect similar sales in the fourth quarter. …
…
continue reading
1
100. The Genspace Genesis: How Bio Design Connects People and the Planet with Dan Grushkin
58:05
58:05
Mais Tarde
Mais Tarde
Listas
Like
Curtido
58:05
In this milestone 100th episode, Karl and Erum look back on collaborations like the biosecurity event with Andrew Hessel and the U.S.-India Next Gen Materials event, while also acknowledging the establishment of the Chumash Heritage National Marine Sanctuary. Erum and Karl are also joined by special guest Dan Grushkin to explore the evolving world …
…
continue reading
1
Biotech beyond earth: The future of medicine in space
39:01
39:01
Mais Tarde
Mais Tarde
Listas
Like
Curtido
39:01
LinkGevity, founded by two sisters, is developing anti-necrotic technologies, especially for application in kidney disease. Carina Kern is the CEO of the company, while Serena Kern-Libera is the chief operating officer. After reading an article about how space-travel is especially damaging to the kidneys, they applied for a place on the inaugural N…
…
continue reading
1
Pharma and Biotech Daily: Novo Nordisk's Semaglutide Shows Promise in Alzheimer's Prevention, Roche's Billion Dollar Gene Therapy Deal, Off-Label GLP-1 Use on the Rise
1:01
1:01
Mais Tarde
Mais Tarde
Listas
Like
Curtido
1:01
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. A study has found that Novo Nordisk's semaglutide may reduce the risk of Alzheimer's disease by 40% to 70%. Roche has entered a potential $1 billion gene therapy deal with Dyno Therapeutics, focusing on neurological diseas…
…
continue reading
1
A Smarter Path to Curing Diseases… Dr. Avak Kahvejian Founding CEO, Cellarity
19:44
19:44
Mais Tarde
Mais Tarde
Listas
Like
Curtido
19:44
Dr. Avak Kahvejian, Founding CEO of Cellarity, explains their new approach to discovering drugs by using AI to look at how cells behave as a whole, rather than focusing on one part of the problem. This approach could lead to faster development of better treatments, such as a pill for sickle cell disease.…
…
continue reading
1
🧬Neela Patel - Bonum Therapeutics - Part 2 | Leading an Academic Microbiology Lab | The Value of Personal Relationships in the Workplace | Leading a Team & Learning on the Job | The Volatility of an Acquisition ...
38:27
38:27
Mais Tarde
Mais Tarde
Listas
Like
Curtido
38:27
The Biotech Startups Podcast is brought to you by Excedr. Excedr provides life science startups with equipment leases on founder-friendly terms to accelerate R&D and commercialization. Know anyone that needs lab equipment? Join Excedr’s referral program: Give Your Friends $1,000, and Earn $1,000 for Each Qualified Referral 💸. Get your unique referr…
…
continue reading
1
Pharma and Biotech Daily: Your Essential Industry Update
1:02
1:02
Mais Tarde
Mais Tarde
Listas
Like
Curtido
1:02
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Roche CEO opposes Novo Holdings' acquisition of Catalent, urging for it to be blocked. Roche exceeded Q3 sales expectations, driven by the success of drugs like Ocrevus and Vabysmo. Pfizer's RSV vaccine has been approved …
…
continue reading
1
100: From Raw Data to Actionable Insights: Unlocking the Power of Process Models with Fabian Feidl - Part 2
18:01
18:01
Mais Tarde
Mais Tarde
Listas
Like
Curtido
18:01
Send us a text Imagine predicting your bioprocess outcomes as easily as checking the weather forecast. Sound impossible? Not anymore. In this insightful episode, we dive deep into the world of digital twins and process models with Fabian Feidl, co-founder and CTO of DataHow. Discover how these cutting-edge tools are reshaping the biotech landscape,…
…
continue reading
1
Pharma and Biotech Daily: Roche Drops Alzheimer's Treatment, Starboard Targets Kenvue, and More Industry Updates
0:58
0:58
Mais Tarde
Mais Tarde
Listas
Like
Curtido
0:58
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Roche has ended its collaboration with UCB on Alzheimer's treatments, marking the third candidate dropped by Roche this year. Meanwhile, activist investor Starboard has set its sights on Kenvue, a division of J&J, follow…
…
continue reading
1
Revolutionizing Heart Health: Bitterroot Bio’s Bold Vision with CEO Pavan Cheruvu
43:07
43:07
Mais Tarde
Mais Tarde
Listas
Like
Curtido
43:07
Synopsis: Discover how Bitterroot Bio is poised to revolutionize cardiovascular health in this captivating conversation between host Rahul Chaturvedi and CEO Pavan Cheruvu. Pavan opens up about his inspiring journey from engineering to leading a biotech company at the forefront of cardio-immunology. Learn how his visionary leadership is driving inn…
…
continue reading
1
Supercharging Biotechs: The Power of Strategic Board Engagement
35:24
35:24
Mais Tarde
Mais Tarde
Listas
Like
Curtido
35:24
How can biotech CEOs and their boards foster strong, trusting relationships that drive effective decision-making and long-term success? In this episode of Emerging Biotech Leader, host Kim Kushner explores this critical question together with Don de Bethizy. Don is a seasoned life sciences executive with over 30 years of experience, having served a…
…
continue reading
1
Pharma and Biotech Daily: Your Quick Update on the Latest in the Industry
2:09
2:09
Mais Tarde
Mais Tarde
Listas
Like
Curtido
2:09
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer ResearchIn a groundbreaking study published in Nature Medicine, researchers have identified a new potential target for cancer therapy. This discovery could lead to more effective treatments for a…
…
continue reading
1
99: From Raw Data to Actionable Insights: Unlocking the Power of Process Models with Fabian Feidl - Part 1
22:00
22:00
Mais Tarde
Mais Tarde
Listas
Like
Curtido
22:00
Send us a text Are you ready to decode the future of bioprocessing? In this eye-opening episode, we dive deep into the world of digital bioprocess development with Fabian Feidl, co-founder and CTO of DataHow. Discover how cutting-edge process models are transforming the biotech industry, bridging the gap between raw data and actionable insights. Ke…
…
continue reading
1
Obesity Tx End-Around With Skye Bioscience's Punit Dhillon
1:02:41
1:02:41
Mais Tarde
Mais Tarde
Listas
Like
Curtido
1:02:41
We love to hear from our listeners. Send us a message. While the trend toward CB1 inhibition for obesity took a small hit with the release of Novo Nordisk's small molecule oral cannabinoid receptor (CB1) inverse agonist monlunabant last month, Skye Bioscience Chairman and CEO Punit Dhillon is shaking it off. He's confident that his company's antibo…
…
continue reading
1
🧬 Neela Patel - Bonum Therapeutics - Part 1 | Growing Up in an Intellectual Household | How One Biology Class Inspired Her | Working With Influential Scientists at DNAX | Pursuing the Intersection of Science ...
41:02
41:02
Mais Tarde
Mais Tarde
Listas
Like
Curtido
41:02
Part 1 of 4: Jon Chee hosts our latest guest, Neela Patel, Chief Business Officer at Bonum Therapeutics who are developing protein therapeutics to be used to treat a wide range of diseases. Neela is a seasoned scientist and business development executive with over 30 years of leadership experience in drug discovery and development. Before her time …
…
continue reading
1
Pharma and Biotech Daily: Keeping You Informed on the Latest in the Industry
2:36
2:36
Mais Tarde
Mais Tarde
Listas
Like
Curtido
2:36
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. ## New Drug Approval: Title: FDA Approves New Cancer Drug for Treatment of Breast CancerContent: The FDA has approved a new cancer drug for the treatment of breast cancer. This new drug is expected to provide better outc…
…
continue reading
1
Trees that Survive Citrus Greening - Gary England
50:50
50:50
Mais Tarde
Mais Tarde
Listas
Like
Curtido
50:50
Citrus greening disease or HLB has severely impacted Florida citrus production. And while many solutions have been proposed, there is interest in a number of trees that have shown to not show symptoms of the disease. This week's episode discusses the disease with retired extension specialist Gary England as he evaluates "survivor" trees. These tree…
…
continue reading
1
10 Resume Mistakes That Might Cost You Your Dream Job
21:49
21:49
Mais Tarde
Mais Tarde
Listas
Like
Curtido
21:49
In this episode, I explore 10 common resume mistakes that might be hindering your biotech job search. Drawing from my recent BioSpace column and observations, I offer practical advice on pitfalls to avoid, such as using profile pictures, fancy formatting, and not proofreading. I emphasize the importance of a professional email address and discuss t…
…
continue reading
1
99. Petri Dish to Podcast: How 100 Episodes Helped Us Grow (and Evolve)
25:54
25:54
Mais Tarde
Mais Tarde
Listas
Like
Curtido
25:54
Erum and Karl reflect on their journey of producing nearly 100 episodes over two years. They discuss the challenges of consistency, the behind-the-scenes work required, and the evolution of their podcast from a simple idea to a platform that amplifies voices in the biotech space. Highlights include their gratitude to guests and collaborators, feedb…
…
continue reading
Today, gene therapy is at an exciting inflection point as the industry moves beyond the first generation of these therapies. However, challenges and barriers remain in bringing gene therapies to market, particularly as they expand into more prevalent diseases. Spur Therapeutics is a clinical-stage biotech company dedicated to developing next genera…
…
continue reading
1
Pharma and Biotech Daily: Key Updates in the Industry
0:59
0:59
Mais Tarde
Mais Tarde
Listas
Like
Curtido
0:59
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Sanofi has signed a $326 million deal with Orano Med for radiopharma, following a similar deal made in September. Sage Therapeutics is laying off 33% of employees to support the launch of its postpartum depression drug. …
…
continue reading